title: Generation and characterization of peptide mimotopes specific for anti ErbB-2 monoclonal antibodies.
abstract: The erbb-2 gene receptor is often over-expressed in human cancer and its overexpression is accompanied by worse prognosis. Targeting erbb-2 gene with antibodies is an effective approach to curtail the progression of erbb-2 gene-expressing cancer types. Two monoclonal antibodies, L-26 and N-12, previously generated in our laboratory, have shown effective tumor inhibition in mice, especially when used in combination. Here, we describe novel peptide mimics of erbb-2 gene protein epitopes, also called mimotopes, that were selected from a constraint random 12-mer peptide phage library, specific for the antibodies L-26 and N-12. Initial sequencing analyses revealed little sequence conservation among the peptide mimotopes, and no sequence homology with the erbb-2 gene protein. However, computational analyses of the two groups of peptides, specific for L-26 and N-12, suggested different epitopes on the erbb-2 gene extracellular domain. In vitro assays showed that the phage displayed peptide mimotopes were specific to their respective antibodies. Selected cyclic peptide mimotopes, but not their corresponding linear equivalents, were able to inhibit binding of the antibodies L-26 and N-12 to the surface of erbb-2 gene-expressing cancer cells in a concentration-dependent manner. In line with this observation, phage-displayed cyclic peptides successfully competed in vitro with recombinant erbb-2 gene protein for binding to their respective antibodies L-26 or N-12. Consistent with the antibody inhibition experiments, we detected specific anti-erbb-2 gene antibodies following vaccination with KLH-coupled cyclic peptides but not with multiple antigenic linear peptides. Potentially, the selected peptides could serve as a starting point for the development of a vaccine against erbb-2 gene over-expressing cancer.
authors: Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
authors: Esther J
authors: EJ
authors: Witsch
authors: Georg
authors: G
authors: Mahlknecht
authors: Jean
authors: J
authors: Wakim
authors: Rotem
authors: R
authors: Sertchook
authors: Erez
authors: E
authors: Bublil
authors: Yosef
authors: Y
authors: Yarden
authors: Michael
authors: M
authors: Sela
references: J Natl Cancer Inst. 2005 Nov 16;97(22):1663-70
references: 16288119
references: J Immunol. 1995 Apr 1;154(7):3162-72
references: 7534789
references: Cancer Cell. 2009 May 5;15(5):429-40
references: 19411071
references: Cancer Cell. 2004 Apr;5(4):317-28
references: 15093539
references: Immunol Lett. 2000 Dec 1;75(1):61-7
references: 11163868
references: N Engl J Med. 2006 Jun 15;354(24):2619-21
references: 16775247
references: Cancer Cell. 2006 Jul;10(1):25-38
references: 16843263
references: Clin Cancer Res. 1995 Nov;1(11):1311-8
references: 9815926
references: Bioinform Biol Insights. 2009 Jul 01;3:71-81
references: 20140073
references: Vaccine. 2007 Jan 22;25(6):970-5
references: 17055124
references: J Neuroimmunol. 2010 Aug 25;225(1-2):68-76
references: 20546938
references: Proc Natl Acad Sci U S A. 1989 Dec;86(23):9084-8
references: 2480595
references: Curr Protoc Immunol. 2001 May;Chapter 9:Unit 9.6
references: 18432861
references: J Mol Biol. 2003 Nov 14;334(1):87-101
references: 14596802
references: Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):4995-5000
references: 10220407
references: J Clin Oncol. 2010 Mar 1;28(7):1138-44
references: 20124182
references: EMBO J. 1997 Aug 15;16(16):4938-50
references: 9305636
references: Nat Med. 2000 Apr;6(4):443-6
references: 10742152
references: Cancer Immunol Immunother. 2006 Jun;55(6):717-27
references: 16151804
references: Cancer Immunol Immunother. 2010 Oct;59(10):1481-7
references: 20544195
references: Cancer Res. 2008 Sep 15;68(18):7502-11
references: 18794138
references: Mol Oncol. 2007 Jun;1(1):42-54
references: 19383286
references: Oncogene. 2010 Aug 12;29(32):4517-27
references: 20514015
references: Nat Rev Cancer. 2005 May;5(5):341-54
references: 15864276
references: Curr Protoc Immunol. 2002 Nov;Chapter 9:Unit 9.8
references: 18432894
references: Oncogene. 1997 May 1;14(17):2099-109
references: 9160890
references: Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3294-9
references: 19218427
references: Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8691-5
references: 1717984
references: FASEB J. 1998 Dec;12(15):1635-42
references: 9837853
references: Curr Opin Mol Ther. 2000 Feb;2(1):74-9
references: 11249654
references: Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):1915-20
references: 15684082
references: Proc Natl Acad Sci U S A. 1986 Dec;83(23):9129-33
references: 3466178
references: Nature. 2003 Feb 13;421(6924):756-60
references: 12610629
references: Nat Rev Mol Cell Biol. 2001 Feb;2(2):127-37
references: 11252954
references: J Immunol. 2007 Jun 1;178(11):7120-31
references: 17513761
references: J Mol Biol. 1982 May 5;157(1):105-32
references: 7108955
references: J Clin Oncol. 2008 Apr 10;26(11):1789-96
references: 18347005
references: J Biol Chem. 1996 Mar 29;271(13):7620-9
references: 8631797
references: Vaccine. 1997 Aug;15(11):1276-85
references: 9286056
references: FASEB J. 2000 Nov;14(14):2177-84
references: 11053238
references: Proc Natl Acad Sci U S A. 1992 May 15;89(10):4285-9
references: 1350088
references: Oncologist. 2004;9 Suppl 3:10-5
references: 15163842
references: J Mol Neurosci. 2004;24(1):105-13
references: 15314258
references: Cancer Res. 2009 Dec 15;69(24):9330-6
references: 19934333
references: Curr Protoc Neurosci. 2001 May;Chapter 5:Unit 5.6
references: 18428505
references: Nucleic Acids Res. 2001 May 15;29(10):E50-0
references: 11353095
references: Bioinformatics. 2009 May 1;25(9):1189-91
references: 19151095
references: Proc Natl Acad Sci U S A. 1988 Aug;85(15):5409-13
references: 3399498
references: Nat Rev Drug Discov. 2007 May;6(5):404-14
references: 17473845
references: Proteins. 2007 Jul 1;68(1):294-304
references: 17427229
references: J Immunol. 2001 Apr 15;166(8):5271-8
references: 11290813
references: Eur J Immunol. 1994 Nov;24(11):2868-73
references: 7525309
references: J Clin Oncol. 1999 Sep;17(9):2639-48
references: 10561337
references: J Immunol. 2004 Jul 1;173(1):394-401
references: 15210798